Drug profile · INN
desvenlafaxine succinate
DESVENLAFAXINE SUCCINATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
desvenlafaxine succinate (DESVENLAFAXINE SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN desvenlafaxine succinate
Brand DESVENLAFAXINE SUCCINATE
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Frequently asked questions
What is desvenlafaxine succinate?
desvenlafaxine succinate (DESVENLAFAXINE SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for desvenlafaxine succinate?
DESVENLAFAXINE SUCCINATE is a marketed brand name for desvenlafaxine succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desvenlafaxine succinate?
desvenlafaxine succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.